entertainment -WSS

entertainment

author：leisure time 2025-10-02 22:57:50 - browse：55151

Stock photo of a heart monitor function on an apple watch — Adobe

As wearable health devices grow more popular in the U.S., there’s a growing opportunity to track the broader adult population’s heart health. But it’s much harder for an Apple Watch to accurately detect the heart’s electrical signals and rhythm than a set of hospital-grade electrodes. Its readings are messier, often because of poor contact with the skin.

A team of Yale researchers published a paper in Nature this month exploring a potential solution: an artificial intelligence algorithm trained on noisy electrocardiograms, electrical pulse recordings that illustrate heart function. Starting an algorithm off with this data could help it more easily adapt to the reality of imperfect wearable sensors.

“You could say I’m going to find the clean, pristine-looking ECG that looks a lot more like the ECG done in a clinical setting, and only use those for diagnostics,” said study author Rohan Khera, a cardiologist and data scientist at Yale. “But that’s not the reality. Clinical ECGs are not obtained on wristwatches.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Medical mystery: When a cough is not just a cough

focus

hotspot

WSS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

PhRMA lawsuit over Medicare drug price negotiation tossed

Report cites 'urgent' need to recruit more diverse clinical trial participants

Bernie Sanders gets little from pharma CEOs on drug prices

Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

entertainment

explore

Malaria cases in Florida and Texas: Here’s what you need to know

BioAge raises $170M for combination therapy with Zepbound

ChatGPT in medicine: STAT answers readers' burning questions

Biogen Alzheimer’s drug launch off to slow start

Psychedelics group wrestles with new pharma identity

Gilead might be held responsible for not developing a drug

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: How biotech is using artificial intelligence

Cancer drug shortages should be causing more outrage

PhRMA lawsuit over Medicare drug price negotiation tossed

hotspot

Why did Pfizer dish out millions for a Super Bowl ad?

KalVista pill reduced swelling 'attacks' caused by genetic disease

Congress must protect the remaining independent doctors

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Long Covid research funding gets a major boost from NIH

Biden report: The neurospychology of memory and aging

focus

hotspot

focus

Wikipedia